Cargando…

Computational Investigations of Traditional Chinese Medicinal Compounds against the Omicron Variant of SARS-CoV-2 to Rescue the Host Immune System

Macrodomain-I of the NSP3 (non-structural protein 3) is responsible for immune response hijacking in the SARS-CoV-2 infection known as COVID-19. In the omicron variant (B.1.1.529), this domain harbors a new mutation, V1069I, which may increase the binding of ADPr and consequently the infection sever...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naman, Ziad Tareq, Kadhim, Salim, Al-Isawi, Zahraa J. K., Butch, Christopher J., Muhseen, Ziyad Tariq
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227372/ https://www.ncbi.nlm.nih.gov/pubmed/35745660 http://dx.doi.org/10.3390/ph15060741

Ejemplares similares

Integrated computer-aided drug design and biophysical simulation approaches to determine natural anti-bacterial compounds for Acinetobacter baumannii
por: Almihyawi, Raed A. H., et al.
Publicado: (2022)

Insights into the Binding of Receptor-Binding Domain (RBD) of SARS-CoV-2 Wild Type and B.1.620 Variant with hACE2 Using Molecular Docking and Simulation Approaches
por: Muhseen, Ziyad Tariq, et al.
Publicado: (2021)

Stress as a possible cause of a high incidence of hypertension and diabetes and a low incidence of asthma in the Iraqi population
por: Al-Isawi, Zahraa, et al.
Publicado: (2023)

Promising Terpenes as Natural Antagonists of Cancer: An In-Silico Approach
por: Muhseen, Ziyad Tariq, et al.
Publicado: (2019)

Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2
por: Muhseen, Ziyad Tariq, et al.
Publicado: (2021)

Utilization of aqueous broccoli florets extract for green synthesis and characterization of silver nanoparticles, with potential biological applications
por: Abdulazeem, Lubna, et al.
Publicado: (2023)

Molecular modeling and molecular dynamics simulation study of the human Rab9 and RhoBTB3 C-terminus complex
por: Junaid, Muhammad, et al.
Publicado: (2014)

Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach
por: Muhseen, Ziyad Tariq, et al.
Publicado: (2020)

Determination of Novel Anti-Cancer Agents by Targeting OGG1 Enzyme Using Integrated Bioinformatics Methods
por: Muhseen, Ziyad Tariq, et al.
Publicado: (2021)

The emergence of the Omicron variant
por: Toovey, Oliver T.R., et al.
Publicado: (2022)

Molecular Insights into Binding Mode and Interactions of Structure-Based Virtually Screened Inhibitors for Pseudomonas aeruginosa Multiple Virulence Factor Regulator (MvfR)
por: Almihyawi, Raed A. H., et al.
Publicado: (2021)

Omicron adopts a different strategy from Delta and other variants to adapt to host
por: Du, Xiaohong, et al.
Publicado: (2022)

Computational Modeling and Evaluation of Potential mRNA and Peptide-Based Vaccine against Marburg Virus (MARV) to Provide Immune Protection against Hemorrhagic Fever
por: Albaqami, Faisal F., et al.
Publicado: (2023)

Development of a Novel Vaccine Candidates against Cardiobacterium valvarum through Reverse Vaccinology and Computational Approaches
por: Albaqami, Faisal F., et al.
Publicado: (2023)

Heterogeneity of the Omicron variant in Senegal
por: Diédhiou, Cyrille Kouligueul, et al.
Publicado: (2022)

Reproduction Number of the Omicron Variant Triples That of the Delta Variant
por: Du, Zhanwei, et al.
Publicado: (2022)

mRNA-Based Vaccine Designing against Epstein-Barr Virus to Induce an Immune Response Using Immunoinformatic and Molecular Modelling Approaches
por: Althurwi, Hassan N., et al.
Publicado: (2022)

A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model
por: Ma, Jian, et al.
Publicado: (2023)

Computational design of medicinal compounds to inhibit RBD-hACE2 interaction in the Omicron variant: unveiling a vulnerable target site
por: Shahab, Muhammad, et al.
Publicado: (2023)

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
por: Rössler, Annika, et al.
Publicado: (2022)

Short-Term and Long-Term COVID-19 Pandemic Forecasting Revisited with the Emergence of OMICRON Variant in Jordan
por: Hussein, Tareq, et al.
Publicado: (2022)

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
por: Karim, Salim S Abdool, et al.
Publicado: (2021)

Reduced antigenicity of Omicron lowers host serologic response
por: Tubiana, Jérôme, et al.
Publicado: (2022)

Aktuelle Informationen zur Omicron-Variante
por: Hasibeder, Walter
Publicado: (2022)

Omicron: a mysterious variant of concern
por: Gowrisankar, A., et al.
Publicado: (2022)

Rescuing Low Frequency Variants within Intra-Host Viral Populations directly from Oxford Nanopore sequencing data
por: Liu, Yunxi, et al.
Publicado: (2021)

Rescuing low frequency variants within intra-host viral populations directly from Oxford Nanopore sequencing data
por: Liu, Yunxi, et al.
Publicado: (2022)

Decoupling of omicron variant infections and severe COVID-19
por: Madhi, Shabir A, et al.
Publicado: (2022)

Novel Chimeric Vaccine Candidate Development against Leptotrichia buccalis
por: Alshammari, Abdulrahman, et al.
Publicado: (2022)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
por: Zang, Jinkai, et al.
Publicado: (2022)

SARS-CoV-2 dual infection with Delta and Omicron variants in an immunocompetent host: a case report
por: Abroi, Aare, et al.
Publicado: (2022)

Drug-likeness analysis of traditional Chinese medicines: 1. property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional Chinese medicines
por: Shen, Mingyun, et al.
Publicado: (2012)

Preparation for the challenge of heavily mutated Omicron variant
por: Song, Yuanlin, et al.
Publicado: (2021)

Omicron variant infection and the associated immunological scenario
por: Goutam Mukherjee, Anirban, et al.
Publicado: (2022)

Omicron variant and booster COVID-19 vaccines
por: Burki, Talha Khan
Publicado: (2022)

World Facing the latest variant of Concern---------Omicron
por: Javaid, Muhammad Mohsin, et al.
Publicado: (2022)

COVID-19 Omicron variant-induced laryngitis
por: Kimura, Yurika, et al.
Publicado: (2023)

Omicron variant may protect against flu
por: Wong, Carissa
Publicado: (2022)

COVID vaccine booster doses for omicron variants
por: Burki, Talha
Publicado: (2022)

Will New Variants Emerge after Delta and Omicron?
por: Yang, Zhen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_193ro6d2rbetjb2m59837vvhug